www.bewet.fora.pl

loczytzn

Trends in the biotechnology industry in Japan

. Using cell culture technology to produce seeds and tissue culture seedlings, urokinase,[link widoczny dla zalogowanych], D an interferon, a one interferon and ginseng. Sales of these products in Japan, 19 years totaled lO00iZ yen figure, some units more than 700 million U.S. dollars. In addition, the Japanese market, there are a variety of support equipment and the use of biotechnology enzymatic conversion process produces a variety of medicines and foods. The former, such as chromatography system, automatic equipment, polymerase chain reaction, DNA sequence analysis and Taiwan into the device, peptide sequence analysis of Taiwan into the instrument. Biosensors, cell melt bed system, three-dimensional protein structure analysis software, etc.; the latter, such as hyaluronic acid, Y to save the bamboo through a high-linolenic acid from u1991.1, single cell protein, oligonucleotides, cyclodextrin, oil classes and fat, these products and equipment market is expanding rapidly. Japan's biotechnology-related private companies focused on the following four areas of research and development and production and sales. Pharmaceutical company Eli Lilly product areas and mountains of Japan within the pharmaceutical company began selling in 1989, growth hormone, Y an interferon (cancer agent) and erythropoietin (EPO, anemia disease) has also been approved by the Central Pharmaceutical Affairs Bureau. According to the forecast,[link widoczny dla zalogowanych], EPO huge market, Kirin Brewery Company and foreign pharmaceutical companies have been approved for production. Y Suntory has applied for interferon as a therapeutic agent for skin cancer. Kirin Brewery Company,[link widoczny dla zalogowanych], Suntory and Chinese and foreign pharmaceutical companies have applied for the production of granulocyte colony stimulating factor (an effective drug in treatment of cancer and infectious diseases). Production is expected to propose oKT-3 (inhibitor of renal transplant rejection) of the application. Clinical trials of new drugs are now are: derivatives of interleukin-1B,[link widoczny dla zalogowanych], interleukin-a 1a, a granulocyte macrophage colony stimulating factor and the second generation of tPA. I expected to soon begin clinical trials were: epidermal growth factor, human monoclonal antibody (anti virus), interleukin _6 and a herpes vaccine. Some diagnostic drugs are being developed and commercialized. The main non-A hepatitis B diagnosis and treatment of inflammation of the drug. DNA probe into the market soon. For example, a Toray Fuji Bionics plans to sell a used to diagnose tumor virus (which can cause cervical cancer) DNA probe. Japan textile company's first pharmaceutical company and Mitsubishi Petrochemical companies are also developing DNA probes. Fine Chemicals Company is vigorously developing field of detergent with enzymes. Toyo Sugar textile companies and plans to begin production in Hokkaido, a recombinant protein Takeda Pharmaceutical Company and Asahi Kasei Chemicals Corporation is the construction of amino acid factories abroad. Food processing industry is mainly the bioreactor used in food production. For example, Kao company sells a special kind of emulsified oil (immobilized lipase with a bioreactor production), for the production of bread. Nitt0 Secretary Denko ~ z} of a sale of a mixed ginseng (produced by tissue culture) of tofu. Fuji Oil Company immobilized lipase bioreactor mountain mountain Yu Yu oleic acid, an acid (BOB) oil; Meiji confectionery company producing chocolate with the oil, causing the trading community attention. Agriculture Japanese agriculture is a positive application of biotechnology in the field. Application of plant tissue culture in agriculture, based on the emergence of seedlings industry. Some of the major seed companies (such as the first seed company) and other companies involved in biotechnology (such as Nippon Steel and Mitsubishi Kasei Corporation) has begun production of plug-type seedlings. With the transfer from seed to seedlings, bio-industry, the company began to shift production with higher value products; present supercomputer market in Japan accounts for 80% of the world market, but only two U.S. companies doing business in Japan . Japan had promised, by 1991, the U.S. semiconductor; body products accounted for the Japanese market share of 2O%, but so far failed to break lo%. ; The United States has also accused Western Europe the use of unfair competitive practices, such as to \But the West; Europe against each other, argue that the United States in 1988, the number of U.S. aircraft firm orders increased. ; 48%, profits increased by 28%,[link widoczny dla zalogowanych], share of world market share has increased to gaze intently former 51'6. , While Airbus's share of world market share of only l7.2%. In addition, the United States and Europe in electronic products through:; communication equipment trade quarrels have occurred, could lead to large-scale sanctions and counter-sanctions. EC:; is likely in the next five years, the electronics industry in the region to implement protective measures, giving rise to trade:; war. i!. . . . ... -. -. -. .... . ... -. ... -. . _. . . . . .... . ~ -. .... . -. ... -. . . .... . -. ... -. .... . .... . .... . ... -. A 32-bamboo technology through a listless machine 1991.1

相关的主题文章：

[link widoczny dla zalogowanych]

[link widoczny dla zalogowanych]

[link widoczny dla zalogowanych]